3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
5
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
1
Fallopian Tube Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Interventions
Paclitaxel
20
Carboplatin
18
Cisplatin
12
Topotecan
6
Docetaxel
5
Gemcitabine
4
Etoposide
3
rubitecan
2
Taxes
2
Surgical Procedures, Operative
2
Filgrastim
2
Erlotinib Hydrochloride
2
Cyclophosphamide
2
vandetanib
1
sargramostim
1
pegfilgrastim
1
motesanib diphosphate
1
liposomal doxorubicin
1
liposomal amphotericin B
1
Watchful Waiting
1
Vorinostat
1
Trabectedin
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
Pemetrexed
1
Ondansetron
1
Neoadjuvant Therapy
1
Mitoxantrone
1
Mifepristone
1
Mass Spectrometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Carcinoma, Ovarian Epithelial
×
Cytoreduction Surgical Procedures
×
Clear all
NCT00008138
2016-01-08
S0009
SWOG Cancer Research Network
Phase 2
Completed
62 enrolled
9 charts